Blood Pressure and Cardiovascular Risk 2020: Cutting Edge Prevention Applied to Various Populations in the Age of COVID-19

REGISTRATION IS NOW CLOSED. 

“Please note that Penn Medicine is following the CDC guidelines to stop the spread of COVID-19 (Coronavirus) through social distancing. In the event Blood Pressure and Cardiovascular Risk 2020 cannot move forward as a live-attended conference, all pre-registered attendees will be moved to Live Stream. Please be sure you will be able to join the conference through live stream and review our cancellation policy before you register.”

Cardiovascular disease is the leading cause of death in the United States. Hypertension and diabetes are among the foremost risk factors for the development of cardiovascular diseases, including stroke, peripheral artery disease, and heart attack. Several advances have been made in recent years to improve our ability to prevent the development and progression of cardiovascular disease. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on optimal pharmacotherapy in specific high-risk patient populations, lifestyle interventions for the management of hypertension, and non-pharmacologic approaches to cardiovascular risk prevention.

1. Identify appropriate blood pressure goals in patients with increased risk of cardiovascular events
2. Select appropriate medications to reduce adverse cardiovascular outcomes in high-risk and vulnerable populations
3. Achieve competence in providing the best screening and treatment options for hypertension in patients with refractory hypertension, pregnant patients, young patients, and cancer patients
4. Review the controversies regarding the appropriate management of hypertension in select high-risk hypertensive populations
5. Apply appropriate pharmacologic and non-pharmacologic approaches to cardiovascular risk prevention

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This program provides 4.75 contact hours. 

Pharmacists: This knowledge-based activity is approved for 4.75 ACPE contact hours of continuing pharmacy education credit. JA0000324-0000-20-018-L04-P.

Physician Assistants: Penn Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 4.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

In order to process refunds for course withdrawals, cancellations must be received in writing by September 18, 2020 (subject to a service charge of $10.00). No refunds will be issued thereafter.

The University reserves the right to cancel or postpone any course due to unforeseen circumstances. In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines, and travel agencies.

Friday, October 2, 2020